| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.055 | 0.2 |